Abstract:Drug-induced blockade of the human ether-à-go-go-related gene (hERG) channel is today considered the main cause of cardiotoxicity in postmarketing surveillance. Hence, several ligand-based approaches were developed in the last years and are currently employed in the early stages of a drug discovery process for in silico cardiac safety assessment of drug candidates. Herein, we present the first structure-based classifiers able to discern hERG binders from nonbinders. LASSO regularized support vector machines were applied to integrate docking scores and protein–ligand interaction fingerprints. A total of 396 models were trained and validated based on: (i) high-quality experimental bioactivity information returned by 8337 curated compounds extracted from ChEMBL (version 25) and (ii) structural predictor data. Molecular docking simulations were performed using GLIDE and GOLD software programs and four different hERG structural models, namely, the recently published structures obtained by cryoelectron microscopy (PDB codes: 5VA1 and 7CN1) and two published homology models selected for comparison. Interestingly, some classifiers return performances comparable to ligand-based models in terms of area under the ROC curve (AUCMAX = 0.86 ± 0.01) and negative predictive values (NPVMAX = 0.81 ± 0.01), thus putting forward the herein proposed computational workflow as a valuable tool for predicting hERG-related cardiotoxicity without the limitations of ligand-based models, typically affected by low interpretability and a limited applicability domain. From a methodological point of view, our study represents the first example of a successful integration of docking scores and protein–ligand interaction fingerprints (IFs) through a support vector machine (SVM) LASSO regularized strategy. Finally, the study highlights the importance of using hERG structural models accounting for ligand-induced fit effects and allowed us to select the best-performing protein conformation (made available in the Supporting Information, SI) to be employed for a reliable structure-based prediction of hERG-related cardiotoxicity.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jcim.1c00744.Top views of the BS of all of the employed protein models and the number of active and inactive compounds as a consequence of the selected activity and inactivity thresholds (Figures S1 and S2 and Tables S1) (PDF)Kolmogorov–Smirnov test p-values summarizing the difference in docking score distributions between hERG binders and nonbinders, the SE and SP of all of the developed models, the BS volumes (Å3) of all of the used hERG models, and the interactions responsible for a lower IC50 based on the KS test performed on the IFs returned by all of the considered protein models (Tables S2–S6) (PDF)List of the compounds belonging to the hERG-DB, including SMILES strings and corresponding IC50 values (XLSX)Results of the performed docking simulations including docking scores and molecular interaction fingerprints (ZIP)Results of the performed docking simulations including molecular interaction fingerprints (ZIP)5VA1-IFD-1, 5VA1-IFD-2, 5VA1-IFD-3, 5VA1-IFD-4, and 5VA1-IFD-5 conformations as. pdb files (ZIP)This article has not yet been cited by other publications.

Antihistamines modulate the integrin signaling pathway in h9c2 rat cardiomyocytes

QSAR Study on Rat Cardiotoxicity of Chemical Component of Chinese Herbs

Transcriptome, Network Analysis, and Molecular Docking Approaches to Elucidate the Modes of Action of Astragaloside IV Against Myocardial Infarction with Mitochondrial Energy Metabolism Network-Targeted Regulation

Identification of potential genomic biomarkers for early detection of chemically induced cardiotoxicity in rats

Exposure to Acrylamide Disrupts Cardiomyocyte Interactions During Ventricular Morphogenesis in Zebrafish Embryos.

Mining Potential Drug Targets and Constructing Diagnostic Models for Heart Failure Based on Mirna-Mrna Networks

In silico prediction of hERG blockers using machine learning and deep learning approaches

Bioinformatic Analysis of Key Genes in Cardiotoxic Compound Induced Long QT Interval

Arrhythmogenic Effect of Sympathetic Histamine in Mouse Hearts Subjected to Acute Ischemia

Identification of novel biomarkers involved in doxorubicin-induced acute and chronic cardiotoxicity, respectively, by integrated bioinformatics

Structure-Based Prediction of hERG-Related Cardiotoxicity: A Benchmark Study

ADMET Evaluation in Drug Discovery. 16. Predicting Herg Blockers by Combining Multiple Pharmacophores and Machine Learning Approaches.

A Comprehensive Cardiotoxicity Assay by Combining High-Throughput Multiple Ion Channel Screening with Human Cardiomyocyte-Based Action Potential Validation

Identification of ATRNL1 and WNT9A as novel key genes and drug candidates in hypertrophic cardiomyopathy: integrative bioinformatics and experimental validation

Machine learning and deep learning approaches for enhanced prediction of hERG blockade: a comprehensive QSAR modeling study

Weighted gene co-expression network-based approach to identify key genes associated with anthracycline-induced cardiotoxicity and construction of miRNA-transcription factor-gene regulatory network

Ligand-based prediction of hERG-mediated cardiotoxicity based on the integration of different machine learning techniques

Quercetin is a foe in the heart by targeting the hERG potassium channel

Biomimetic integrated gustatory and olfactory sensing array based on HL-1 cardiomyocyte facilitating drug screening for tachycardia treatment

Histamine Deficiency Aggravates Cardiac Injury Through Mir-206/216B-atg13 Axis-Mediated Autophagic-Dependant Apoptosis

A stacking ensemble machine learning model for evaluating cardiac toxicity of drugs based on in silico biomarkers